Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Acclaimed Scientist To Lead Arthritis National Research Foundation (ANRF)
  • USA - English


News provided by

Arthritis National Research Foundation

Mar 09, 2018, 03:00 ET

Share this article

Share toX

Share this article

Share toX

LONG BEACH, Calif. (PRWEB) March 09, 2018 -- Today the Arthritis National Research Foundation (ANRF, CureArthritis.org) announced the appointment of Zaher Nahle, PhD, MPA, as its new Executive Director (ED). This is the outcome of a rigorous, nation-wide search examining many extraordinary candidates.

A statement from the search committee of the board revealed that, “The committee was determined to find a uniquely qualified individual who is simultaneously an inspirational leader, a proven executive, and a compassionate soul. We found all that and more in Dr. Nahle - We cannot be more thrilled to welcome him to our fold to lead the new era of growth and development. ANRF is poised to play an even more dynamic role in the disease space and this development is a tremendous step forward.”

Dr. Nahle is an award-winning scientist with interdisciplinary training in biomedical research and public administration. He has a history of securing prestigious funding in healthcare and patient-oriented research and has generated millions of dollars for scientific endeavors. He holds a PhD in Physiology and Biophysics from Stony Brook University/Cold Spring Harbor Laboratory (New York) and an MPA from Harvard University, where he also completed a fellowship in public policy and management at the John F. Kennedy School of Government.

Prior to joining ANRF, Dr. Nahle was the Chief Scientific Officer and Vice President for Research at Solve ME/CFS Initiative (SMCI), a Los Angeles-based nonprofit organization dedicated to Myalgic Encephalomyelitis, also known as Chronic Fatigue Syndrome, a complex and debilitating disease related to the research portfolio of ANRF. In this capacity, he oversaw a comprehensive investment program with medical centers and industry partners to increase biomedical research into this disease. He also directed a robust scientific portfolio including peer-review grant programs in basic, translational and epidemiology research, as well as specialized biobanking services and Electronic Health Record platforms. Dr. Nahle also developed numerous medical education, research communication and community engagement initiatives.

Dr. Nahle is a frequent speaker at international conferences and serves on specialized committees and panels at federal agencies, including the NIH and the CDC. Earlier in his career, he was on the faculty of leading universities, such as Weill Cornell Medicine and Vanderbilt University. While at Harvard, he co-founded a nonprofit organization focused on the disability agenda in Africa. Dr. Nahle’s research work is featured and published in prestigious journals like Science and Nature. He received numerous awards including ones from the American Heart Association (AHA), the Department of Defense (DoD), the Robert Wood Johnson Foundation (RWJF)/Genetic Alliance (GA), and was an Edward Mason fellow at Harvard University.

Gale A. Granger, PhD, a longtime ANRF board member and a professor Emeritus at UC Irvine, whose groundbreaking work shaped modern approaches to therapeutic modalities in Arthritis and cancer research believes that, “Dr. Nahle’s recruitment will help propel the Foundation to new heights and make ANRF the key driver of scientific innovation in Arthritis and associated diseases.” Hon. Sally Anne Sheridan, who is on the ANRF board and served as the Mayor of the City of Irvine agrees: “We were very impressed with Dr. Nahle’s vison and background and have great confidence in his ability to lead CureArthritis.org at this critical point in its growth.”

“I am very humbled to be the one entrusted by this truly formidable board of directors, working alongside an all-star scientific board, a dedicated group of colleagues, and our wonderful volunteers,” Dr. Nahle said. “This is an incredible opportunity to serve patients through finding solutions for a complex, multifactorial disease. I live with arthritis myself, so I know the challenges firsthand. For the longest time, I have been impressed by the pioneering work that ANRF has created in accelerating the discovery process and challenging the status quo – ANRF supports the most promising ideas from the brightest MD and PhD investigators at the most formative stages in their careers. Going forward, we remain laser-focused on that mission and I firmly believe that our contributions will continue to be exciting and transformative.”

---------

Since 1970, the Arthritis National Research Foundation, a tax deductible charity based in Long Beach, CA, has supported outstanding young scientists who have become innovators and leaders in the field of rheumatic disease research, autoimmunity, inflammation and molecular genetics. From the discovery of Tumor Necrosis Factor (the molecule that initiates inflammation in arthritis) to genes involved in lupus, their research accomplishments have made a long-lasting impact. Support arthritis research with an online donation at CureArthritis.org.

For all media inquiries please contact Derek Belisle at derek(at)curearthritis.org Dr. Nahle can be reached directly at znahle(at)curearthritis.org.

Derek Belisle, Arthritis National Research Foundation, http://CureArthritis.org, +1 562-437-6808, [email protected]

Modal title

Zaher Nahle, PhD
Zaher Nahle, PhD
Zaher Nahle, PhD

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.